• Something wrong with this record ?

A new perspective on drug-resistant epilepsy in children with focal cortical dysplasia type 1: From challenge to favorable outcome

B. Splitkova, K. Mackova, M. Koblizek, Z. Holubova, M. Kyncl, K. Bukacova, A. Maulisova, B. Straka, M. Kudr, M. Ebel, A. Jahodova, A. Belohlavkova, GAR. Rivera, M. Hermanovsky, P. Liby, M. Tichy, J. Zamecnik, R. Janca, P. Krsek

. 2025 ; 66 (3) : 632-647. [pub] 20241226

Language English Country United States

Document type Journal Article

OBJECTIVE: We comprehensively characterized a large pediatric cohort with focal cortical dysplasia (FCD) type 1 to expand the phenotypic spectrum and to identify predictors of postsurgical outcomes. METHODS: We included pediatric patients with histopathological diagnosis of isolated FCD type 1 and at least 1 year of postsurgical follow-up. We systematically reanalyzed clinical, electrophysiological, and radiological features. The results of this reanalysis served as independent variables for subsequent statistical analyses of outcome predictors. RESULTS: All children (N = 31) had drug-resistant epilepsy with varying impacts on neurodevelopment and cognition (presurgical intelligence quotient [IQ]/developmental quotient scores = 32-106). Low presurgical IQ was associated with abnormal slow background electroencephalographic (EEG) activity and disrupted sleep architecture. Scalp EEG showed predominantly multiregional and often bilateral epileptiform activity. Advanced epilepsy magnetic resonance imaging (MRI) protocols identified FCD-specific features in 74.2% of patients (23/31), 17 of whom were initially evaluated as MRI-negative. In six of eight MRI-negative cases, fluorodeoxyglucose-positron emission tomography (PET) and subtraction ictal single photon emission computed tomography coregistered to MRI helped localize the dysplastic cortex. Sixteen patients (51.6%) underwent invasive EEG. By the last follow-up (median = 5 years, interquartile range = 3.3-9 years), seizure freedom was achieved in 71% of patients (22/31), including seven of eight MRI-negative patients. Antiseizure medications were reduced in 21 patients, with complete withdrawal in six. Seizure outcome was predicted by a combination of the following descriptors: age at epilepsy onset, epilepsy duration, long-term invasive EEG, and specific MRI and PET findings. SIGNIFICANCE: This study highlights the broad phenotypic spectrum of FCD type 1, which spans far beyond the narrow descriptions of previous studies. The applied multilayered presurgical approach helped localize the epileptogenic zone in many previously nonlesional cases, resulting in improved postsurgical seizure outcomes, which are more favorable than previously reported for FCD type 1 patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009720
003      
CZ-PrNML
005      
20250429134557.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/epi.18237 $2 doi
035    __
$a (PubMed)39724384
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Splitkova, Barbora $u Department of Pediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic $1 https://orcid.org/0000000234627421
245    12
$a A new perspective on drug-resistant epilepsy in children with focal cortical dysplasia type 1: From challenge to favorable outcome / $c B. Splitkova, K. Mackova, M. Koblizek, Z. Holubova, M. Kyncl, K. Bukacova, A. Maulisova, B. Straka, M. Kudr, M. Ebel, A. Jahodova, A. Belohlavkova, GAR. Rivera, M. Hermanovsky, P. Liby, M. Tichy, J. Zamecnik, R. Janca, P. Krsek
520    9_
$a OBJECTIVE: We comprehensively characterized a large pediatric cohort with focal cortical dysplasia (FCD) type 1 to expand the phenotypic spectrum and to identify predictors of postsurgical outcomes. METHODS: We included pediatric patients with histopathological diagnosis of isolated FCD type 1 and at least 1 year of postsurgical follow-up. We systematically reanalyzed clinical, electrophysiological, and radiological features. The results of this reanalysis served as independent variables for subsequent statistical analyses of outcome predictors. RESULTS: All children (N = 31) had drug-resistant epilepsy with varying impacts on neurodevelopment and cognition (presurgical intelligence quotient [IQ]/developmental quotient scores = 32-106). Low presurgical IQ was associated with abnormal slow background electroencephalographic (EEG) activity and disrupted sleep architecture. Scalp EEG showed predominantly multiregional and often bilateral epileptiform activity. Advanced epilepsy magnetic resonance imaging (MRI) protocols identified FCD-specific features in 74.2% of patients (23/31), 17 of whom were initially evaluated as MRI-negative. In six of eight MRI-negative cases, fluorodeoxyglucose-positron emission tomography (PET) and subtraction ictal single photon emission computed tomography coregistered to MRI helped localize the dysplastic cortex. Sixteen patients (51.6%) underwent invasive EEG. By the last follow-up (median = 5 years, interquartile range = 3.3-9 years), seizure freedom was achieved in 71% of patients (22/31), including seven of eight MRI-negative patients. Antiseizure medications were reduced in 21 patients, with complete withdrawal in six. Seizure outcome was predicted by a combination of the following descriptors: age at epilepsy onset, epilepsy duration, long-term invasive EEG, and specific MRI and PET findings. SIGNIFICANCE: This study highlights the broad phenotypic spectrum of FCD type 1, which spans far beyond the narrow descriptions of previous studies. The applied multilayered presurgical approach helped localize the epileptogenic zone in many previously nonlesional cases, resulting in improved postsurgical seizure outcomes, which are more favorable than previously reported for FCD type 1 patients.
650    _2
$a lidé $7 D006801
650    12
$a refrakterní epilepsie $x chirurgie $x diagnostické zobrazování $x patofyziologie $7 D000069279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a dítě $7 D002648
650    12
$a elektroencefalografie $x metody $7 D004569
650    _2
$a předškolní dítě $7 D002675
650    12
$a malformace mozkové kůry, skupina I $x chirurgie $x komplikace $x diagnostické zobrazování $7 D065703
650    _2
$a výsledek terapie $7 D016896
650    12
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a mladiství $7 D000293
650    _2
$a pozitronová emisní tomografie $7 D049268
650    _2
$a kohortové studie $7 D015331
650    _2
$a malformace mozkové kůry $x chirurgie $x komplikace $x diagnostické zobrazování $7 D054220
650    _2
$a kojenec $7 D007223
650    _2
$a fokální kortikální dysplazie $7 D000092222
650    _2
$a epilepsie $7 D004827
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mackova, Katerina $u Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic $1 https://orcid.org/0000000185680006
700    1_
$a Koblizek, Miroslav $u Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic $1 https://orcid.org/000000028422732X
700    1_
$a Holubova, Zuzana $u Department of Radiology, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic $1 https://orcid.org/0009000040464473
700    1_
$a Kyncl, Martin $u Department of Radiology, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic $1 https://orcid.org/0000000162106351
700    1_
$a Bukacova, Katerina $u Department of Clinical Psychology, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic $1 https://orcid.org/0000000261241583
700    1_
$a Maulisova, Alice $u Department of Clinical Psychology, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic $1 https://orcid.org/0000000170268238
700    1_
$a Straka, Barbora $u Department of Pediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic $1 https://orcid.org/0000000184482833
700    1_
$a Kudr, Martin $u Department of Pediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic $1 https://orcid.org/0000000178533446
700    1_
$a Ebel, Matyas $u Department of Pediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic $1 https://orcid.org/000000024795152X
700    1_
$a Jahodova, Alena $u Department of Pediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic
700    1_
$a Belohlavkova, Anezka $u Department of Pediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic $1 https://orcid.org/0000000184626892
700    1_
$a Rivera, Gonzalo Alonso Ramos $u Department of Pediatrics, Martin University Hospital, Jessenius Faculty of Medicine in Martin, Martin, Slovak Republic $1 https://orcid.org/0009000341840321
700    1_
$a Hermanovsky, Martin $u Department of Water Resources and Environmental Modeling, Faculty of Environmental Sciences, Czech University of Life Sciences Prague, Prague, Czech Republic $1 https://orcid.org/0000000283559840
700    1_
$a Liby, Petr $u Department of Neurosurgery, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic $1 https://orcid.org/000000018392795X
700    1_
$a Tichy, Michal $u Department of Neurosurgery, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic
700    1_
$a Zamecnik, Josef $u Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic
700    1_
$a Janca, Radek $u Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic $1 https://orcid.org/0000000308251069
700    1_
$a Krsek, Pavel $u Department of Pediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, full member of the European Reference Network EpiCARE, Prague, Czech Republic $1 https://orcid.org/0000000257403690
773    0_
$w MED00001567 $t Epilepsia $x 1528-1167 $g Roč. 66, č. 3 (2025), s. 632-647
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39724384 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429134552 $b ABA008
999    __
$a ok $b bmc $g 2311222 $s 1246801
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 66 $c 3 $d 632-647 $e 20241226 $i 1528-1167 $m Epilepsia $n Epilepsia $x MED00001567
LZP    __
$a Pubmed-20250415

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...